QBiotics Group Limited
4 clinical trials · Sponsor
◉ Watch QBiotics Group Limited
| Record | Firm | Date |
|---|---|---|
| A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue Sarcoma (NCT05755113) | QBiotics Group Limited | 2023-04-13 |
| A Clinical Study to Investigate the Efficacy of Tigilanol Tiglate Directly in Head and Neck Cancer (NCT05608876) | QBiotics Group Limited | 2022-11-03 |
| A Trial of Intratumoural Tigilanol Tiglate in Adult Participants With Stage IIIB to IV M1c Melanoma (NCT05234437) | QBiotics Group Limited | 2022-03-09 |
| A Trial of Tigilanol Tiglate in Combination With Pembrolizumab in Stage IIIB to IV M1c-melanoma (NCT04834973) | QBiotics Group Limited | 2021-05-07 |
Track QBiotics Group Limited automatically
Every clearance here is in the API, with alerts when new ones post.